Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies

Hormone and Metabolic Research

Volumn 47, Issue 10, 2015, Pages 727-734

  Morshed, S A ^a,b   Davies, T F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Graves' disease; signaling; thyroid; TSH; TSH receptor antibodies

Indexed keywords

AUTOANTIBODY; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LYMPHOCYTE ANTIGEN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PROTEIN KINASE B; PROTEIN KINASE C; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 4; THYROID STIMULATING HORMONE RECEPTOR ANTIGEN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; GRAVES DISEASE; HUMAN; HUMORAL IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID CELL; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; GRAVES DISEASE; HUMANS; IMMUNITY, HUMORAL; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION;

EID: 84941549885     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0035-1559633     Document Type: Article

References (50)

1. Bahn R. S., Dutton C. M., Natt N., Joba W., Spitzweg C., Heufelder A. E. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab: 1998; 83 998 1002
2. Chazenbalk G. D., Pichurin P., Chen C. R., Latrofa F., Johnstone A. P., McLachlan S. M., Rapoport B. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest: 2002; 110 209 217
3. Kajita Y., Rickards C. R., Buckland P. R., Howells R. D., Rees S. B. Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem J: 1985; 227 413 420
4. Loosfelt H., Pichon C., Jolivet A., Misrahi M., Caillou B., Jamous M., Vannier B., Milgrom E. Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci USA: 1992; 89 3765 3769
5. Vlase H., Davies T. F. Insights into the molecular mechanisms of the autoimmune thyroid diseases. In: Endocrine and Organ Specific Autoimmunity. Eisenbarth G. S. (ed.) CA R. G. Landes Co: 1999; 98 132
6. Bagriacik E. U., Klein J. R. The thyrotropin (thyroid-stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD45RBhigh lymph node T cells: functional role for thyroid-stimulating hormone during immune activation. J Immunol: 2000; 164 6158 6165
7. Meffre E., Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol: 2008; 20 632 638
8. Gilbert J. A., Kalled S. L., Moorhead J., Hess D. M., Rennert P., Li Z., Khan M. Z., Banga J. P. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology: 2006; 147 4561 4568
9. Lai Kwan L. Q., King Hung K. O., Zheng B. J., Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA: 2008; 105 14993 14998
10. Salvi M., Vannucchi G., Campi I., Rossi S., Bonara P., Sbrozzi F., Guastella C., Avignone S., Pirola G., Ratiglia R., Beck-Peccoz P. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur J Endocrinol: 2006; 154 511 517
11. Adams D. D., Purves H. D. Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med School: 1956; 34 11 12
12. Ando T., Davies T. F. Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol: 2005; 12 137 143
13. Ando T., Latif R., Pritsker A., Moran T., Nagayama Y., Davies T. F. A monoclonal thyroid-stimulating antibody. J Clin Invest: 2002; 110 1667 1674
14. Ando T., Latif R., Davies T. F. Antibody-induced modulation of TSH receptor post-translational processing. J Endocrinol: 2007; 195 179 186
15. Ando T., Latif R., Daniel S., Eguchi K., Davies T. F. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology: 2004; 145 5185 5193
16. Mizutori Y., Chen C. R., McLachlan S. M., Rapoport B. The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Mol Endocrinol: 2008; 22 1171 1182
17. Mueller S., Jaeschke H., Gunther R., Paschke R. The hinge region: an important receptor component for GPHR function. Trends Endocrinol Metab: 2010; 21 111 122
18. Morshed S. A., Ma R., Latif R., Davies T. F. How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis. J Autoimmun: 2013; 47 17 24
19. Morshed S. A., Latif R., Davies T. F. Delineating the autoimmune mechanisms in Graves' disease. Immunol Res: 2012; 54 191 203
20. Morshed S. A., Ando T., Latif R., Davies T. F. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades. Endocrinology: 2010; 151 5537 5549
21. Costagliola S., Many M. C., Denef J. F., Pohlenz J., Refetoff S., Vassart G. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest: 2000; 105 803 811
22. Sanders J., Allen F., Jeffreys J., Bolton J., Richards T., Depraetere H., Nakatake N., Evans M., Kiddie A., Premawardhana L. D., Chirgadze D. Y., Miguel R. N., Blundell T. L., Furmaniak J., Smith B. R. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid: 2005; 15 672 682
23. Muehlberg T., Gilbert J. A., Rao P. V., McGregor A. M., Banga J. P. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease. Endocrinology: 2004; 145 1539 1545
24. Sanders J., Allen F., Jeffreys J., Bolton J., Richards T., Depraetere H., Nakatake N., Evans M., Kiddie A., Premawardhana L. D., Chirgadze D. Y., Miguel R. N., Blundell T. L., Furmaniak J., Smith B. R. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid: 2005; 15 672 682
25. Sanders J., Jeffreys J., Depraetere H., Evans M., Richards T., Kiddie A., Brereton K., Premawardhana L. D., Chirgadze D. Y., Nunez M. R., Blundell T. L., Furmaniak J., Rees S. B. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid: 2004; 14 560 570
26. Nagy E. V., Burch H. B., Mahoney K., Lukes Y. G., Morris J. C. III, Burman K. D. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun: 1992; 188 28 33
27. Sanders J., Chirgadze D. Y., Sanders P., Baker S., Sullivan A., Bhardwaja A., Bolton J., Reeve M., Nakatake N., Evans M., Richards T., Powell M., Miguel R. N., Blundell T. L., Furmaniak J., Smith B. R. Crystal Structure of the TSH Receptor in Complex with a Thyroid-Stimulating Autoantibody. Thyroid: 2007; 17 395 410
28. Latif R., Teixeira A., Michalek K., Ali M. R., Schlesinger M., Baliram R., Morshed S. A., Davies T. F. Antibody protection reveals extended epitopes on the human TSH receptor. PLoS One: 2012; 7 e44669
29. Morshed S. A., Latif R., Davies T. F. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology: 2009; 150 519 529
30. Sanders P., Young S., Sanders J., Kabelis K., Baker S., Sullivan A., Evans M., Clark J., Wilmot J., Hu X., Roberts E., Powell M., Nunez Miguel R., Furmaniak J., Rees Smith B. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol: 2011; 46 81 99
31. Evans M., Sanders J., Tagami T., Sanders P., Young S., Roberts E., Wilmot J., Hu X., Kabelis K., Clark J., Holl S., Richards T., Collyer A., Furmaniak J., Smith B. R. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol (Oxf): 2010; 73 404 412
32. Davies T. F., Ando T., Lin R. Y., Tomer Y., Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest: 2005; 115 1972 1983
33. Vives-Pi M., Rodriguez-Fernandez S., Pujol-Autonell I. How apoptotic beta-cells direct immune response to tolerance or to autoimmune diabetes: a review. Apoptosis: 2015; 20 263 272
34. Mao J., Yuan H., Xie W., Wu D. Guanine nucleotide exchange factor GEF115 specifically mediates activation of Rho and serum response factor by the G protein alpha subunit Galpha13. Proc Natl Acad Sci USA: 1998; 95 12973 12976
35. Back C. M., Stohr S., Schafer E. A., Biebermann H., Boekhoff I., Breit A., Gudermann T., Buch T. R. TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling. J Mol Endocrinol: 2013; 51 79 90
36. Zaballos M. A., Garcia B., Santisteban P. Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Mol Endocrinol: 2008; 22 1183 1199
37. Ye R. D. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol: 2001; 70 839 848
38. Aaronson D. S., Horvath C. M. A road map for those who don't know JAK-STAT. Science: 2002; 296 1653 1655
39. Stassi G., De M. R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol: 2002; 2 195 204
40. Wang S. H., Baker J. R. The role of apoptosis in thyroid autoimmunity. Thyroid: 2007; 17 975 979
41. Mao C., Wang S., Xiao Y., Xu J., Jiang Q., Jin M., Jiang X., Guo H., Ning G., Zhang Y. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. J Immunol: 2011; 186 4734 4743
42. Bossowski A., Czarnocka B., Bardadin K., Stasiak-Barmuta A., Urban M., Dadan J., Ratomski K., Bossowska A. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis. Autoimmunity: 2008; 41 163 173
43. Bossowski A., Czarnocka B., Bardadin K., Urban M., Niedziela M., Dadan J. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Horm Res: 2008; 70 155 164
44. Newby P. R., Roberts-Davies E. L., Brand O. J., Heward J. M., Franklyn J. A., Gough SC L., Simmonds M. J. Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clinical Endocrinology: 2007; 67 125 128
45. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell: 2010; 140 619 630
46. Marchi S., Giorgi C., Suski J. M., Agnoletto C., Bononi A., Bonora M., De Marchi E., Missiroli S., Patergnani S., Poletti F., Rimessi A., Duszynski J., Wieckowski M. R., Pinton P. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct: 2012; 2012 329635
47. Mano T., Shinohara R., Iwase K., Kotake M., Hamada M., Uchimuro K., Hayakawa N., Hayashi R., Nakai A., Ishizuki Y., Nagasaka A. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res: 1997; 29 351 354
48. Gimenez-Barcons M., Colobran R., Gomez-Pau A., Marin-Sanchez A., Casteras A., Obiols G., Abella R., Fernandez-Doblas J., Tonacchera M., Lucas-Martin A., Pujol-Borrell R. Graves' Disease TSHR-Stimulating Antibodies (TSAbs) Induce the Activation of Immature Thymocytes: A Clue to the Riddle of TSAbs Generation? J Immunol: 2015; 194 4199 4206
49. Kamath C., Young S., Kabelis K., Sanders J., Adlan M. A., Furmaniak J., Rees Smith B., Premawardhana L. D. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema. Clin Endocrinol (Oxf): 2012; 77 465 470
50. Takasu N., Yamada T., Sato A., Nakagawa M., Komiya I., Nagasawa Y., Asawa T. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clin Endocrinol (Oxf): 1990; 33 687 698